International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC-hpNSC, a neural stem cell program that has completed the Phase I clinical trial for...
19 insider purchases on record · latest filing 2014-08-08.
Insiders have also filed 1 sale transaction at ISCO.